Early antenatal care is important for optimal maternal and foetal health
FDA approves new drug treatment for chronic weight management, first since 2014, Food and Drug Administration (2021) Once-weekly semaglutide in adults with overweight or obesity, New England Journal of Medicine (2021) Updates about Wegovy, Novo Nordisk (2024) Medications containing semaglutide marketed for type 2 diabetes or weight loss, FDA (2024) Drug shortages, Food and Drug Administration (2024) Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension, Diabetes, Obesity & Metabolism (2022) FDA approves Lillys Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes, Lilly Investors (2022) FDA approves new medication for chronic weight management, Food and Drug Administration (2023) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
On a day when Hims & Hers likely expected to be riding the high from its Super Bowl commercial, the telehealth company found itself playing defense following a lawsuit from Novo Nordisk.
Refund requests are reviewed individually by our support team
Making smart choices about medications like Tums is just one part of your ongoing commitment to your health after weight loss surgery
Compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug
